Fig. 3
In silico analysis using Alamut software. ATM variants identified in PBMCs derived from two familial breast cancer patients (BC patient#1 and #2) and one breast-thyorid cancer patient (BTC patient#7) lead to an increased affinity and/or appearance of a de novo sites for SR proteins